Budapest, Hungary

Antal Gajáry

This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-Aventis. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antal Gajáry. Retrieved from https://idiyas.com/inventor/antal-gajáry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antal Gajáry: Innovator in Pharmaceutical Chemistry

Introduction

Antal Gajáry is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approach to chemical processes.

Latest Patents

Gajáry's latest patents include a process for the chloromethylation of thiophene. This process involves the preparation of 2-chloromethyl-thiophene, which serves as an intermediate for several pharmaceutically active ingredients. His second patent focuses on the resolution process for (R)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid. This invention details the preparation of the compound by resolving the corresponding racemic compound using specific chemical formulas.

Career Highlights

Antal Gajáry is currently employed at Sanofi-Aventis, a leading global pharmaceutical company. His work there emphasizes the importance of innovation in developing new pharmaceutical compounds and processes.

Collaborations

Throughout his career, Gajáry has collaborated with esteemed colleagues such as Zsolt Dombrády and Mátyás Aradi. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Antal Gajáry's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to influence the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…